# US 2026/0027255 A1 · Cross-Linked Telechelic Polymer Compositions, Methods of Preparation Thereof, and Methods of Using Same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0027255 A1
- Document ID: US20260027255A1
- Status: Published application
- Kind: A1
- Application number: 18/998,070
- Filed: 2023-07-24
- Published: 2026-01-29
- Earliest claimed: 2022-07-25
- Assignees: Betty Yu Skin Technology Advisors, LLC
- Applicants: Betty Yu Skin Technology Advisors, LLC
- Inventors: Betty Yu
- Web page: https://patentgrep.com/patent/US20260027255A1

## CPC

- A61L 26/0019: {obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds}
- C08L 83/04: Polysiloxanes
- A61K 8/25: Silicon; Compounds thereof
- A61K 8/891: saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
- A61K 9/107: Emulsions {; Emulsion preconcentrates; Micelles (composition of emulsions A61K47/00)}
- A61K 31/196: the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
- A61K 31/351: not condensed with another ring
- A61K 31/4174: Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
- A61K 31/4745: condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines (yohimbine derivatives, vinblastine A61K31/475; ergoline derivatives A61K31/48)
- A61K 31/496: Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A61K 31/513: having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
- A61K 31/573: substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
- A61K 31/7036: having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
- A61K 33/04: Sulfur, selenium or tellurium; Compounds thereof
- A61K 38/12: Cyclic peptides {, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C (A61K38/043 - A61K38/046 take precedence)}
- A61K 47/02: Inorganic compounds
- A61K 47/34: Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence)
- A61L 26/0061: {Use of materials characterised by their function or physical properties}
- C08G 77/12: containing silicon bound to hydrogen
- C08G 77/20: containing silicon bound to unsaturated aliphatic groups
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C08G: MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS

## Abstract

The present disclosure relates, in part, to cross-linked telechelic polymer compositions and methods of preparation thereof. In another aspect, the present disclosure relates to multilayer compositions comprising an adhesive base (AB) and a mechanically reinforcing composition (MRC), methods of preparation thereof, and methods of use thereof. In certain embodiments, the in situ prepared compositions are suitable for application to the skin of a subject for treating a wound and/or skin condition.

## Claims

### Claim 1

A telechelic polymer composition comprising a cross-linked reaction product of any of:
(i) at least one polysiloxane (a) comprising a number of diorganosiloxy monomers, at least one 1-alkenyl-1-organosiloxy monomer, and two termini, wherein each terminus is independently selected from a triorganosiloxy group and a 1,1-organo-1-alkenyl-siloxy group, and wherein at least three Si atoms present in the polysiloxane are alkenyl-substituted;
(ii) at least one polysiloxane (b) comprising a number of diorganosiloxy monomers, a number of 1-organo-hydrosiloxy monomers, and two termini, wherein each terminus is independently selected from a triorganosiloxy group and a 1,1-diorgano-hydrosiloxy group, and wherein at least two Si atoms present in the polysiloxane are substituted with H (i.e., Si—H);
(iii) at least one polysiloxane (c) comprising a number of diorganosiloxy monomers, optionally a number of 1-alkenyl-1-organo-siloxy monomers, and two termini, wherein each terminus is independently selected from a triorganosiloxy group and a 1,1-diorgano-1-alkenyl-siloxy group, and wherein at least two Si atoms present in the polysiloxane are vinyl-substituted;
(iv) at least one inert formulation-compatible polysiloxane (d); and
(v) at least one Group X transition metal catalyst.

### Claim 2 (depends on 1)

The composition of claim 1, further comprising:
(vi) at least one additional polysiloxane (f), wherein the at least one additional polysiloxane comprises a number of diorganosiloxy monomers, optionally a 1,1-diorgano-hydrosiloxy monomer, and two termini, wherein each terminus is independently selected from a triorganosiloxy group and a 1,1-diorgano-hydrosiloxy group, and wherein one Si atom present in the polysiloxane is substituted with H (i.e., Si—H).

### Claim 3 (depends on 1, 2)

The composition of claim 1 or 2, wherein the at least one polysiloxane (a) is a compound of formula (Ia):
wherein:
A1 comprises m units of
monomer and n units of
monomer,
wherein each ---- bond is a Si—O bond;
m is an integer ranging from 410 to 470;
n is an integer ranging from 1 to 50;
R1a, R1b, R1c, R1d, R1e, and R1f are each independently selected from the group consisting of optionally substituted C1-C6 alkyl, optionally substituted C3-C8 cycloalkyl, optionally substituted C2-C6 heteroalkyl, optionally substituted C1-C8 heterocycloalkyl, optionally substituted benzyl, optionally substituted C6-C10 aryl, optionally substituted C2-C12 heteroaryl, and optionally substituted C2-C6 alkenyl,
wherein R1a, R1b, R1c, R1d, R1e, and R1f are selected such that each Si atom is substituted with no more than one optionally substituted C2-C6 alkenyl; and
R1g, R1h, and R1i are each independently selected from the group consisting of optionally substituted C1-C6 alkyl, optionally substituted C3-C8 cycloalkyl, optionally substituted C2-C6 heteroalkyl, optionally substituted C1-C8 heterocycloalkyl, optionally substituted benzyl, optionally substituted C6-C10 aryl, and optionally substituted C2-C12 heteroaryl.

### Claim 4 (depends on 1, 2, 3)

The composition of any one of claims 1-3, wherein the at least one polysiloxane in (b) is a compound of formula (Ib):
wherein:
R2a, R2b, R2c, R2f, R2g, and R2h are each independently selected from the group consisting of H, optionally substituted C1-C6 alkyl, optionally substituted C3-C8 cycloalkyl, optionally substituted C2-C6 heteroalkyl, optionally substituted C1-C8 heterocycloalkyl, optionally substituted benzyl, optionally substituted C6-C10 aryl, and optionally substituted C2-C12 heteroaryl;
each occurrence of R2d and R2e is independently selected from the group consisting of H, optionally substituted C1-C6 alkyl, optionally substituted C3-C8 cycloalkyl, optionally substituted C2-C6 heteroalkyl, optionally substituted C1-C8 heterocycloalkyl, optionally substituted benzyl, optionally substituted C6-C10 aryl, and optionally substituted C2-C12 heteroaryl;
o is an integer ranging from 500 to 1500; and
wherein R2a, R2b, R2c, R2d, R2e, R2f, R2g and R2h are selected such that each Si atom is substituted with no more than one H atom.

### Claim 5 (depends on 1, 2, 3, 4)

The composition of any one of claims 1-4, wherein the at least one polysiloxane in (c) is a compound of formula (Ic):
wherein:
B1 comprises p units of
monomer and q units of
monomer,
wherein each ---- bond is a Si—O bond;
R3a, R3b, R3c, R3d, R3e, and R3f are each independently selected from the group consisting of optionally substituted C1-C6 alkyl, optionally substituted C3-C8 cycloalkyl, optionally substituted C2-C6 heteroalkyl, optionally substituted C1-C8 heterocycloalkyl, optionally substituted benzyl, optionally substituted C6-CLO aryl, optionally substituted C2-C12 heteroaryl, and optionally substituted C2-C6 alkenyl,
wherein R3a, R3b, R3c, R3d, R3e, and R3f are selected such that each Si atom is substituted with no more than one C2-C6 alkenyl;
R3g, R3h, and R3i are each independently C1-C6 alkyl;
p is an integer ranging from 500 to 2000; and
q is an integer ranging from 0 to 50.

### Claim 6 (depends on 2, 3, 4, 5)

The composition of any one of claims 2-5, wherein the at least one polysiloxane in (f) is a compound of formula (If):
wherein:
R4a, R4b, R4c, R4f, and R4g are each independently selected from the group consisting of H, optionally substituted C1-C6 alkyl, optionally substituted C3-C8 cycloalkyl, optionally substituted C2-C6 heteroalkyl, optionally substituted C1-C8 heterocycloalkyl, optionally substituted benzyl, optionally substituted C6-C10 aryl, and optionally substituted C2-C12 heteroaryl;
each occurrence of R4d and R4e is independently selected from the group consisting of H, optionally substituted C1-C6 alkyl, optionally substituted C3-C8 cycloalkyl, optionally substituted C2-C6 heteroalkyl, optionally substituted C1-C8 heterocycloalkyl, optionally substituted benzyl, optionally substituted C6-C10 aryl, and optionally substituted C2-C12 heteroaryl;
r is an integer ranging from 100 to 400; and
wherein no more than one of R4a, R4b, R4c, R4d, R4c, R4f, R4g, and R4h is H.

### Claim 7 (depends on 1, 2, 3, 4, 5, 6)

The composition of any one of claims 1-6, wherein the Group X catalyst comprises Pt.

### Claim 8 (depends on 7)

The composition of claim 7, wherein the Pt is Pt(0).

### Claim 9 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

The composition of any one of claims 1-8, wherein the Group X catalyst is Karstedt's catalyst:

### Claim 10 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9)

The composition of any one of claims 1-9, wherein the inert formulation-compatible polysiloxane is a compound of formula (Id):
wherein:
R5a, R5b, R5c, R5d, R5e, R5f, R5g, and R5h are each independently C1-C6 alkyl; and
s is an integer ranging from 1 to about 500.

### Claim 11 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The composition of any one of claims 1-10, wherein the inert formulation-compatible polysiloxane is selected from the group consisting of poly dimethylsiloxane, dimethiconol, disiloxane, trisiloxane, and diphenyl dimethicone/vinyl diphenyl dimethicone/silsesquioxane cross-polymer.

### Claim 12 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 11)

The composition of any one of claims 1-9 and 11, wherein the inert formulation-compatible polysiloxane is decamethylcyclopentasiloxane.

### Claim 13 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

The composition of any one of claims 1-12, wherein at least one of the following applies:
(i) R1a, R1b, R1c, R1d, R1c, R1f, R1g, R1h, and R1i are each independently CH3 or CH═CH2;
(ii) R2a, R2b, R2c, R2d, R2e, R2f, R2g, and R2h are each independently H or CH3;
(iii) R3a, R3b, R3c, R3d, R3e, and R3f are each independently CH3 or CH═CH2;
(iv) R3g, R3h, and R3i are each independently CH3 or CH═CH2;
(v) R4a, R4b, R4c, R4d, R4e, R4f, R4g, and R4h are each independently H or CH3; and
(vi) R5a, R5b, R5c, R5d, R5e, R5f, R5g, and R5h are each independently CH3.

### Claim 14 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)

The composition of any one of claims 1-13, wherein the composition further comprises at least one additive.

### Claim 15 (depends on 14)

The composition of claim 14, wherein the at least one additive is at least one selected from the group consisting of glycerin, cetyl diglyceryl tris(trimethylsiloxy)silylethyl dimethicone, hexamethyldisilazane (HMDS) fumed silica, and polyoxyethylene/polyoxypropylene copolymer (PEG/PPG-18/18 dimethicone).

### Claim 16 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)

The composition of any one of claims 1-15, wherein the composition has a viscosity ranging from about 4,000 cSt to about 100,000 cSt.

### Claim 17 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)

The composition of any one of claims 1-16, wherein one of the following applies:
(a) the composition has a viscosity ranging from about 4,000 cSt to about 8,000 cSt; or
(b) the composition has a viscosity ranging from about 30,000 to about 50,000 cSt.

### Claim 18 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

The composition of any one of claims 1-17, wherein the composition has a total ratio of units of silicon hydride (i.e., Si—H) to vinyl-substituted silicon (i.e., Si—C(H)═CH2) in all reactant components ranging from about 0.01 to about 0.8.

### Claim 19 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18)

The composition of any one of claims 1-18, wherein the composition has a total ratio of units of silicon hydride (i.e., Si—H) to vinyl-substituted silicon (i.e., Si—C(H)═CH2) in all polysiloxane reactant components ranging from about 0.4 to about 0.6.

### Claim 20 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19)

The composition of any one of claims 1-19, wherein at least one of the following applies:
(i) the at least one polysiloxane in (a) comprises trimethylsiloxy terminated, 0.8-1.2% vinylmethylsiloxane dimethylsiloxane copolymer;
(ii) the at least one polysiloxane in (b) comprises hydride terminated polydimethylsiloxane;
(iii) the at least one polysiloxane in (c) comprises vinyl terminated polydimethylpolysiloxane;
(iv) the at least one inert formulation-compatible polysiloxane comprises polydimethyl siloxane and/or decamethylcyclopentasiloxane;
(v) the at least one Group X transition metal catalyst comprises Karstedt's catalyst; and
(vi) the at least one additional polysiloxane in (f) comprises monohydride terminated polydimethylpolysiloxane.

### Claim 21 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20)

The composition of any one of claims 1-20, wherein at least one of the following applies:
(vii) the at least one polysiloxane in (a) comprises about 6.0% to about 12.0% of the composition by weight (w/w %);
(viii) the at least one polysiloxane in (b) comprises about 6.0% to about 12.0% of the composition by weight (w/w %);
(ix) the at least one polysiloxane in (c) comprises about 20.0% to about 30.0% of the composition by weight (w/w %);
(x) the at least one formulation-compatible polysiloxane comprises about 10.0% to about 60.0% of the composition by weight (w/w %);
(xi) the at least one Group X catalyst comprises about 0.001% (10 ppm) to about 0.02% (200 ppm) of the composition by weight (w/w %); and
(xii) the at least one additional polysiloxane in (f) comprises about 1.0% to about 10.0% of the composition by weight (w/w %).

### Claim 22 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21)

The composition of any one of claims 1-21, wherein at least one of the following applies:
(vii) the at least one polysiloxane in (a) comprises about 9.0% of the composition by weight (w/w %);
(viii) the at least one polysiloxane in (b) comprises about 9.4% of the composition by weight (w/w %);
(ix) the at least one polysiloxane in (c) comprises about 24.2% of the composition by weight (w/w %);
(x) the at least one formulation-compatible polysiloxane comprises about 49% of the composition by weight (w/w %);
(xi) the at least one Group X catalyst comprises about 0.0048% (48 ppm) of the composition by weight (w/w %); and
(xii) the at least one additional polysiloxane in (f) comprises about 5.8% of the composition by weight (w/w %).

### Claim 23 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20)

The composition of any one of claims 1-20, wherein at least one of the following applies:
(i) the at least one polysiloxane in (a) comprises about 14.0% to about 20.0% of the composition by weight (w/w %);
(ii) the at least one polysiloxane in (b) comprises about 0.20% to about 0.40% of the composition by weight (w/w %);
(iii) the at least one polysiloxane in (c) comprises about 18% to about 40% of the composition by weight (w/w %);
(iv) the at least one formulation-compatible polysiloxane comprises about 35% to about 50% of the composition by weight (w/w %);
(v) the at least one Group X catalyst comprises about 0.0080% (80 ppm) to about 0.0120 (120 ppm) of the composition by weight (w/w %); and
(vi) the at least one additional polysiloxane in (f) comprises about 7% to about 12% of the composition by weight (w/w %).

### Claim 24 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 23)

The composition of any one of claims 1-20 and 23, wherein at least one of the following applies:
(i) the at least one polysiloxane in (a) comprises about 15.5% of the composition by weight (w/w %);
(ii) the at least one polysiloxane in (b) comprises about 0.30% of the composition by weight (w/w %);
(iii) the at least one polysiloxane in (c) comprises about 35.5% of the composition by weight (w/w %);
(iv) the at least one formulation-compatible polysiloxane comprises about 37.3% of the composition by weight (w/w %);
(v) the at least one Group X catalyst comprises about 0.0090% (90 ppm) of the composition by weight (w/w %); and
(vi) the at least one additional polysiloxane in (f) comprises about 8.5% of the composition by weight (w/w %).

### Claim 25 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 23, 24)

The composition of any one of claims 1-20 and 23-24, wherein at least one of the following applies:
(i) the at least one polysiloxane in (a) comprises about 18.90% of the composition by weight (w/w %);
(ii) the at least one polysiloxane in (b) comprises about 0.30% of the composition by weight (w/w %);
(iii) the at least one polysiloxane in (c) comprises about 21.60% of the composition by weight (w/w %);
(iv) the at least one formulation-compatible polysiloxane comprises about 45.1% of the composition by weight (w/w %);
(v) the at least one Group X catalyst comprises about 0.0108% (108 ppm) of the composition by weight (w/w %); and
(vi) the at least one additional polysiloxane in (f) comprises about 10.4% of the composition by weight (w/w %).

### Claim 26 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 23, 24)

The composition of any one of claims 1-20 and 23-24, wherein at least one of the following applies:
(i) the at least one polysiloxane in (a) comprises about 17.18% of the composition by weight (w/w %);
(ii) the at least one polysiloxane in (b) comprises about 0.26% of the composition by weight (w/w %);
(iii) the at least one polysiloxane in (c) comprises about 19.69% of the composition by weight (w/w %);
(iv) the at least one formulation-compatible polysiloxane comprises about 44.00% of the composition by weight (w/w %);
(v) the at least one Group X catalyst comprises about 0.0099% (99 ppm) of the composition by weight (w/w %); and
(vi) the at least one additional polysiloxane in (f) comprises about 9.45% of the composition by weight (w/w %).

### Claim 27 (depends on 1)

A method of preparing the composition of claim 1, the method comprising:
(i) contacting each of the following to provide a first mixture:
at least one polysiloxane in (a) comprising a number of diorganosiloxy monomers, at least one 1-alkenyl-1-organosiloxy monomer, and two termini, wherein each terminus is independently selected from a triorganosiloxy group and a 1,1-organo-1-alkenyl-siloxy group, and wherein at least three Si atoms present in the polysiloxane are alkenyl-substituted;
at least one polysiloxane in (b) comprising a number of diorganosiloxy monomers, a number of 1-organo-hydrosiloxy monomers, and two termini, wherein each terminus is independently selected from a triorganosiloxy group and a 1,1-diorgano-hydrosiloxy group, and wherein at least two Si atoms present in the polysiloxane are substituted with H (i.e., Si—H); and
at least one inert formulation-compatible polysiloxane in (d);
(ii) contacting the first mixture with a Group X transition metal catalyst to provide an at least partially cross-linked mixture; and
(iii) contacting the at least partially cross-linked mixture with:
at least one polysiloxane in (c) comprising a number of diorganosiloxy monomers, optionally a number of 1-alkenyl-1-organo-siloxy monomers, and two termini, wherein each terminus is independently selected from a triorganosiloxy group and a 1,1-diorgano-1-alkenyl-siloxy group, and wherein at least two Si atoms present in the polysiloxane are vinyl-substituted.

### Claim 28 (depends on 1)

A method of preparing the composition of claim 1, the method comprising:
(i) contacting each of the following to provide a first mixture:
at least one polysiloxane in (a) comprising a number of diorganosiloxy monomers, at least one 1-alkenyl-1-organosiloxy monomer, and two termini, wherein each terminus is independently selected from a triorganosiloxy group and a 1,1-organo-1-alkenyl-siloxy group, and wherein at least three Si atoms present in the polysiloxane are alkenyl-substituted; and
at least one polysiloxane in (b) comprising a number of diorganosiloxy monomers, a number of 1-organo-hydrosiloxy monomers, and two termini, wherein each terminus is independently selected from a triorganosiloxy group and a 1,1-diorgano-hydrosiloxy group, and wherein at least two Si atoms present in the polysiloxane are substituted with H (i.e., Si—H);
(ii) contacting the first mixture with at least one inert formulation-compatible polysiloxane (d) and a Group X transition metal catalyst to provide an at least partially cross-linked mixture; and
(iii) contacting the at least partially cross-linked mixture with:
at least one polysiloxane (c) comprising a number of diorganosiloxy monomers, optionally a number of 1-alkenyl-1-organo-siloxy monomers, and two termini, wherein each terminus is independently selected from a triorganosiloxy group and a 1,1-diorgano-1-alkenyl-siloxy group, and wherein at least two Si atoms present in the polysiloxane are vinyl-substituted.

### Claim 29 (depends on 2)

A method of preparing the composition of claim 2, the method comprising:
(vii) contacting each of the following to provide a first mixture:
at least one polysiloxane (a) comprising a number of diorganosiloxy monomers, at least one 1-alkenyl-1-organosiloxy monomer, and two termini, wherein each terminus is independently selected from a triorganosiloxy group and a 1,1-organo-1-alkenyl-siloxy group, and wherein at least three Si atoms present in the polysiloxane are alkenyl-substituted;
least one polysiloxane (f) comprising a number of diorganosiloxy monomers, optionally a 1,1-diorgano-hydrosiloxy monomer, and two termini, wherein each terminus is independently selected from a triorganosiloxy group and a 1,1-diorgano-hydrosiloxy group, and wherein one Si atom present in the polysiloxane is substituted with H (i.e., Si—H);
at least one inert formulation-compatible polysiloxane (d); and
at least one Group X transition metal catalyst;
(viii) contacting the first mixture with the following to provide a second mixture:
at least one polysiloxane (b) comprising a number of diorganosiloxy monomers, a number of 1-organo-hydrosiloxy monomers, and two termini, wherein each terminus is independently selected from a triorganosiloxy group and a 1,1-diorgano-hydrosiloxy group, and wherein at least two Si atoms present in the polysiloxane are substituted with H (i.e., Si—H); and
(ix) contacting the second mixture with:
least one polysiloxane (c) comprising a number of diorganosiloxy monomers, optionally a number of 1-alkenyl-1-organo-siloxy monomers, and two termini, wherein each terminus is independently selected from a triorganosiloxy group and a 1,1-diorgano-1-alkenyl-siloxy group, and wherein at least two Si atoms present in the polysiloxane are vinyl-substituted.

### Claim 30

A mechanically reinforcing composition (MRC) comprising:
(i) at least one polysiloxane (g) comprising a number of diorganosiloxy monomers, optionally a number of 1-alkenyl-1-organo-siloxy monomers, and two termini, wherein each terminus is independently selected from a triorganosiloxy group and a 1,1-diorgano-1-alkenyl-siloxy group, and wherein at least two Si atoms present in the polysiloxane are vinyl-substituted;
(ii) at least one polysiloxane (h) comprising a number of diorganosiloxy monomers, a number of 1-organo-hydrosiloxy monomers, and two termini, wherein each terminus is independently selected from a triorganosiloxy group and a 1,1-diorgano-hydrosiloxy group, and wherein at least two Si atoms present in the polysiloxane are substituted with H (i.e., Si—H);
(iii) at least one reinforcing material; and
(iv) at least one silicone miscible, volatile fluid.

### Claim 31 (depends on 30)

The MRC of claim 30, wherein the composition further comprises at least one non-volatile, silicone miscible fluid.

### Claim 32 (depends on 30, 31)

The MRC of claim 30 or 31, wherein the at least one polysiloxane (g) is a compound of formula (Ig):
wherein:
B2 comprises t units of
monomer and u units of
monomer,
wherein each ---- bond is a Si—O bond;
R6a, R6b, R6c, R6d, R6e, and R6f are each independently selected from the group consisting of optionally substituted C1-C6 alkyl, optionally substituted C3-C8 cycloalkyl, optionally substituted C2-C6 heteroalkyl, optionally substituted C1-C8 heterocycloalkyl, optionally substituted benzyl, optionally substituted C6-C10 aryl, optionally substituted C2-C12 heteroaryl, and optionally substituted C2-C6 alkenyl,
wherein R6a, R6b, R6c, R6d, R6e, and R6f are selected such that each Si atom is substituted with no more than one optionally substituted C2-C6 alkenyl;
R6g, R6h, and R6i are each independently selected from the group consisting of optionally substituted C1-C6 alkyl, optionally substituted C3-C8 cycloalkyl, optionally substituted C2-C6 heteroalkyl, optionally substituted C1-C8 heterocycloalkyl, optionally substituted benzyl, optionally substituted C6-C10 aryl, and optionally substituted C2-C12 heteroaryl;
t is an integer ranging from 300 to 2000; and
u is an integer ranging from 0 to 50.

### Claim 33 (depends on 30, 31, 32)

The MRC of any one of claims 30-32, wherein the at least one polysiloxane (h) is a compound of formula (Ih):
wherein:
A2 comprises v units of
monomer and w units of
monomer,
wherein each ---- bond is a Si—O bond;
R7a, R7b, R7c, R7d, R7e, and R7f are each independently selected from the group consisting of H, optionally substituted C1-C6 alkyl, optionally substituted C3-C8 cycloalkyl, optionally substituted C2-C6 heteroalkyl, optionally substituted C1-C8 heterocycloalkyl, optionally substituted benzyl, optionally substituted C6-C10 aryl, and optionally substituted C2-C12 heteroaryl,
wherein R7a, R7b, R7c, R7d, R7e, and R7f are selected such that each Si atom is substituted with no more than one H atom;
each occurrence of R7g, R7h, and R7i is independently selected from the group consisting of optionally substituted C1-C6 alkyl, optionally substituted C3-C8 cycloalkyl, optionally substituted C2-C6 heteroalkyl, optionally substituted C1-C8 heterocycloalkyl, optionally substituted benzyl, optionally substituted C6-C10 aryl, and optionally substituted C2-C12 heteroaryl;
v is an integer ranging from 10 to 500; and
w is an integer ranging from 2 to 10.

### Claim 34 (depends on 30, 31, 32, 33)

The MRC of any one of claims 30-33, wherein at least one of the following applies:
(d) R6a, R6b, R6c, R6d, R6e, and R6f are each independently selected from the group consisting of CH3 and —CH═CH2;
(e) R6g, R6h, and R6i are each independently CH3;
(c) R7a, R7b, R7c, R7d, R7e, and R7f are each independently selected from the group H and CH3 R6g, R6h, and R6i are each independently CH3; and
(f) R7g, R7h, and R7i are each independently CH3.

### Claim 35 (depends on 30, 31, 32, 33, 34)

The MRC of any one of claims 30-34, wherein the silicone miscible, volatile fluid is at least one selected from the group consisting of disiloxane, trisiloxane, and decamethyl cyclopentasiloxane.

### Claim 36 (depends on 30, 31, 32, 33, 34, 35)

The MRC of any one of claims 30-35, wherein the reinforcing agent is at least one selected from the group consisting of silica and HMDS treated fumed silica.

### Claim 37 (depends on 30, 31, 32, 33, 34, 35, 36)

The MRC of any one of claims 30-36, wherein the composition has a total ratio of units of silicon hydride (i.e., Si—H) to vinyl-substituted silicon (i.e., Si—C(H)═CH2) in all reactant components ranging from about 1 to about 20.

### Claim 38 (depends on 30, 31, 32, 33, 34, 35, 36, 37)

The MRC of any one of claims 30-37, wherein the composition has a total ratio of units of silicon hydride (i.e., Si—H) to vinyl-substituted silicon (i.e., Si—C(H)═CH2) in all reactant components ranging from about 5 to about 7.

### Claim 39 (depends on 30, 31, 32, 33, 34, 35, 36, 37, 38)

The MRC of any one of claims 30-38, wherein the composition further comprises one or more additives.

### Claim 40 (depends on 39)

The MRC of claim 39, wherein the additive is a rheology modifier.

### Claim 41 (depends on 39, 40)

The MRC of claim 39 or 40, wherein the additive is an aesthetic and/or cosmetic modifier.

### Claim 42 (depends on 41)

The MRC of claim 41, wherein the aesthetic and/or cosmetic modifier is at least one selected from the group consisting of vitamin A, vitamin B3, vitamin C, vitamin D, vitamin E, vitamin F, vitamin K, glycolic acid, sunscreen, and/or panthenol.

### Claim 43 (depends on 39, 40, 41, 42)

The MRC of any one of claims 39-42, wherein the additive is a pharmaceutically active compound and/or composition.

### Claim 44 (depends on 43)

The MRC of claim 43, wherein the pharmaceutically active additive is at least one selected from the group consisting of one or more steroids (e.g., mometasone, clobetasol, triamcinolone, fluocinonide, flurandrenolide, clocortolone, halobetasol, desoximetasone, desonide, hydrocortisone, betamethasone, fluticasone, halcinonide, fluocinolone, prednicarbate, diflorasone, flurandrenolide, amcinonide and alclometasone), one or more retinoids (e.g., tretinoin, adapalene, tazarotene, alitretinoin and bexarotene), benzoyl peroxide, azelaic acid, diamino-diphenyl sulphone, one or more JAK inhibitors (e.g., ruxolitinib and delgocitinib), one or more antibiotics (e.g., fusidic acid, mupirocin, retapamulin, silver sulfadiazine, bacitracin, neomycin, polymyxin B, sulfacetamide sodium, sulfur, ozenoxacin, silver sulfadiazine, erythromycin, mafenide, gentamicin, clindamycin, metronidazole, gentamicin, and nadifloxacin), one or more calcineurin inhibitors (e.g., tacrolimus and pimecrolimus), one or more antifungals (e.g., clotrimazole, terbinafine, miconazole, econazole, ketoconazole, tioconazole and amorolfine), becaplermin, 5-fluorouracil, diclofenac, and imiquimod.

### Claim 45 (depends on 35, 36, 37, 38, 39, 40, 41, 42, 43, 44)

The MRC of any one of claims 35-44, wherein at least one of the following applies:
(a) the at least one polysiloxane (g) comprises vinyl terminated dimethylpolysiloxane;
(b) the at least one polysiloxane (h) comprises trimethylsiloxy terminated, pendant silicon-hydride functional poly dimethylsiloxane;
(c) the at least one reinforcing material comprises HMDS treated fumed silica; and
(d) the at least one silicone miscible, volatile fluid comprises decamethyl cyclopentasiloxane.

### Claim 46 (depends on 45)

The MRC of claim 45, wherein at least one of the following applies:
(a) the at least one polysiloxane (g) comprises about 30% to about 50% of the composition by weight (w/w %);
(b) the at least one polysiloxane (h) comprises about 1% to about 10% of the composition by weight (w/w %);
(c) the at least one reinforcing material comprises about 10% to about 30% of the composition by weight (w/w %); and
(d) the at least one silicone miscible, volatile fluid comprises about 35% to about 50% of the composition by weight (w/w %).

### Claim 47 (depends on 45, 46)

The MRC of claim 45 or 46, wherein at least one of the following applies:
(a) the at least one polysiloxane (g) comprises about 36.6% of the composition by weight (w/w %);
(b) the at least one polysiloxane (h) comprises about 6.2% of the composition by weight (w/w %);
(c) the at least one reinforcing material comprises about 14.5% of the composition by weight (w/w %); and
(d) the at least one silicone miscible, volatile fluid comprises about 42.7% of the composition by weight (w/w %).

### Claim 48 (depends on 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44)

The MRC of any one of claims 30-44, wherein at least one of the following applies:
(a) the at least one polysiloxane (g) comprises vinyl terminated dimethylpolysiloxane;
(b) the at least one polysiloxane (h) comprises trimethylsiloxy terminated, pendant silicon-hydride functional poly dimethylsiloxane;
(c) the at least one reinforcing material comprises silica and HMDS treated fumed silica;
(d) the at least one silicone miscible, volatile fluid comprises decamethyl cyclopentasiloxane; and
(e) the at least one non-volatile silicone miscible fluid comprises polydimethylsiloxane fluid.

### Claim 49 (depends on 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 48)

The MRC of any one of claims 30-44 and 48, wherein at least one of the following applies:
(a) the at least one polysiloxane (g) comprises about 20% to about 40% of the composition by weight (w/w %);
(b) the at least one polysiloxane (h) comprises about 1% to about 10% of the composition by weight (w/w %);
(c) the at least one reinforcing material comprises about 10% to about 30% of the composition by weight (w/w %);
(d) the at least one silicone miscible, volatile fluid comprises about 35% to about 50% of the composition by weight (w/w %); and
(e) the at least one non-volatile silicone miscible fluid comprises about 0.1 to about 5% of the composition by weight (w/w %).

### Claim 50 (depends on 49)

The MRC of claim 49, wherein at least one of the following applies:
(a) the at least one polysiloxane (g) comprises about 34.4%, 34.8%, or about 36.2% of the composition by weight (w/w %);
(b) the at least one polysiloxane (h) comprises about 5.8%, 5.9%, or about 6.1% of the composition by weight (w/w %);
(c) the at least one reinforcing material comprises two components which in total comprise about 14.4%, 18.6%, or about 18.8% of the composition by weight (w/w %);
(d) the at least one silicone miscible, volatile fluid comprises about 40.1%, 40.6%, or about 42.3% of the composition by weight (w/w %); and
(e) the at least one non-volatile silicone miscible fluid comprises about 0% or about 1% of the composition by weight (w/w %).

### Claim 51 (depends on 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 48, 49, 50)

The MRC of any one of claims 30-44 and 48-50, wherein at least one of the following applies:
(a) the at least one polysiloxane (g) comprises about 30% of the composition by weight (w/w %);
(b) the at least one polysiloxane (h) comprises about 5% of the composition by weight (w/w %);
(c) the at least one reinforcing material comprises about 22% of the composition by weight (w/w %);
(d) the at least one silicone miscible, volatile fluid comprises about 42% of the composition by weight (w/w %); and
(e) the at least one non-volatile silicone miscible fluid comprises about 0.7% of the composition by weight (w/w %).

### Claim 52 (depends on 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 48, 49, 50, 51)

The MRC of any one of claims 30-44 and 48-51, wherein at least one of the following applies:
(a) the at least one polysiloxane (g) comprises two vinyl terminated dimethylpolysiloxanes;
(b) the at least one polysiloxane (h) comprises two trimethylsiloxy terminated, pendant silicon-hydride functional polydimethylsiloxanes;
(c) the at least one reinforcing material comprises silica and HMDS treated fumed silica; and
(d) the at least one silicone miscible, volatile fluid comprises decamethyl cyclopentasiloxane.

### Claim 53 (depends on 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 52)

The MRC of any one of claims 30-44 and 52, wherein at least one of the following applies:
(a) the at least one polysiloxane (g) comprises about 20% to about 40% of the composition by weight (w/w %);
(b) the at least one polysiloxane (h) comprises about 1% to about 10% of the composition by weight (w/w %);
(c) the at least one reinforcing material comprises about 5% to about 25% of the composition by weight (w/w %); and
(d) the at least one silicone miscible, volatile fluid comprises about 40% to about 60% of the composition by weight (w/w %).

### Claim 54 (depends on 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 52, 53)

The MRC of any one of claims 30-44 and 52-53, wherein at least one of the following applies:
(a) the at least one polysiloxane (g) comprises about 27% of the composition by weight (w/w %);
(b) the at least one polysiloxane (h) comprises about 6% of the composition by weight (w/w %);
(c) the at least one reinforcing material comprises about 13% of the composition by weight (w/w %); and
(d) the at least one silicone miscible, volatile fluid comprises about 54% of the composition by weight (w/w %).

### Claim 55 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54)

A multilayer composition comprising:
(a) an adhesive basal layer comprising the composition of any one of claims 1-26, wherein the adhesive basal layer optionally further comprises one or more additional compounds and/or compositions selected from the group consisting of a non-reactive fluid, emulsifier, a cosmetic, and a pharmaceutically active agent and/or composition;
(b) a mechanically reinforcing layer comprising the MRC of any one of claims 30-54;
wherein the adhesive basal layer is in contiguous contact with at least a portion of a surface of an object; and
wherein the mechanically reinforcing layer is in contiguous contact with at least a portion of the surface of the adhesive basal layer.

### Claim 56 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54)

A method for applying a multilayered wound dressing composition to a wound of a subject, the method comprising:
(a) applying to the surface of the wound an adhesive basal layer comprising the composition of any one of claims 1-26, wherein the adhesive basal layer optionally further comprises one or more additional compounds and/or compositions selected from the group consisting of a non-reactive fluid, emulsifier, and a pharmaceutically active agent and/or composition; and
(b) applying to the surface of the adhesive basal layer a mechanically reinforcing layer comprising the MRC of any one of claims 30-54;
wherein the adhesive basal layer is in contiguous contact with at least a portion of the surface of the wound; and
wherein the mechanically reinforcing layer is in contiguous contact with at least a portion of the surface of the adhesive basal layer.

### Claim 57 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54)

A method of treating a skin condition and/or wound of a subject, the method comprising:
(a) applying to the surface of the wound an adhesive basal layer comprising the composition of any one of claims 1-26, wherein the adhesive basal layer optionally further comprises one or more additional compounds and/or compositions selected from the group consisting of a non-reactive fluid, emulsifier, a cosmetic, and a pharmaceutically active agent and/or composition; and
(b) applying to the surface of the adhesive basal layer a mechanically reinforcing layer comprising the MRC of any one of claims 30-54;
wherein the adhesive basal layer is in contiguous contact with at least a portion of the surface of the wound; and
wherein the mechanically reinforcing layer is in contiguous contact with at least a portion of the surface of the adhesive basal layer.

### Claim 58 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54)

A kit comprising:
(a) a container comprising the composition of any one of claims 1-26, wherein the container is suitable for dispensation;
(b) a container comprising the MRC of any one of claims 30-54, wherein the container is suitable for dispensation; and
(c) instructional materials for use thereof.

### Claim 59

An emulsion composition comprising:
(a) at least one cross-linked telechelic polymer composition,
wherein the at least one cross-linked telechelic polymer composition comprises about 1% to about 25% of the emulsion composition (w/w %);
(b) at least one emulsifier,
wherein the at least one emulsifier comprises about 0.10% to about 10% of the emulsion composition (w/w %);
(c) at least one polar solvent or water-miscible solvent,
wherein the at least one polar solvent or water-miscible solvent comprises about 50% to about 99% of the emulsion composition (v/w %); and
(d) at least one silicone fluid,
wherein the at least one silicone fluid comprises about 1% to about 25% of the emulsion composition (w/w %).

### Claim 60 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 59)

The emulsion of claim 59, wherein at least one of the following applies:
(a) the at least one cross-linked telechelic polymer composition is the composition of any one of claims 1-26;
(b) the at least one cross-linked telechelic polymer composition comprises about 10% of the emulsion composition (w/w %);
(c) the at least one emulsifier comprises cetyl diglyceryl tris(trimethylsiloxy)silylethyl dimethicone;
(d) the at least one emulsifier comprises about 1% of the emulsion composition (w/w %);
(e) the at least one polar solvent or water-miscible solvent comprises at least one selected from the group consisting of 1,3-butylene glycol and glycerin;
(f) the at least one polar solvent or water-miscible solvent comprises about 75% of the emulsion composition (w/w %);
(g) the at least one silicone fluid comprises at least one selected from the group consisting of caprylyl methicone and dimethicone; and
(h) the at least one silicone fluid comprises about 14% of the emulsion composition (w/w %).
